Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Whole Exome Sequencing [WES] market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Whole Exome Sequencing [WES] market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
The Whole Exome Sequencing [WES] market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Whole Exome Sequencing [WES] products across developed and developing countries of the world.
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Whole Exome Sequencing [WES] products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Whole Exome Sequencing [WES] market.
To learn more about this report
Increasing research and development spending on Whole Exome Sequencing [WES] development has been the leading industry trend of Whole Exome Sequencing [WES] market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
To learn more about this report
| Report Attributes | Details |
| The market size value in 2021 | USD XX.XX Million |
| CAGR (2021 - 2028) | XX.XX % |
| The Revenue forecast in 2028 | USD XX.XX Million |
| Base year for estimation | 2021 |
| Historical data | 2018-2019 |
| Forecast period | 2022-2028 |
| Quantitative units |
|
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook | Agilent HaloPlex, Agilent SureSelect, Agilent SureSelect QXT, Illumina TruSeq Exome, Roche Nimblegen SeqCap, MYcroarray MYbaits |
| By Application Outlook | Correlation Research of Normal Human, Mendelian Disease and Rare Syndrome Gene Discovery, The Research of Complex Diseases, Mouse Exome Sequencing |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope | U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled | Illumina, Thermo Fisher, Roche, Angilent, Eurofins, Sengenics, Ambry, Macrogen, BGI, Novo Gene |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Information Procurement
1.2.1 Purchased Database
1.2.2 Eternity’s Internal Database
1.2.3 Secondary sources & third-party perspectives
1.2.4 Primary Research
1.3 Information analysis
1.4 Market formulation & data visualization
1.5 Data validation & publishing
2 Executive Summary
3 Whole Exome Sequencing [WES] Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.2 Market Restraints
3.1.3 Market Challenge Analysis
3.1.4 Market Opportunities
3.1.5 Micro & Macro Indicator
3.2 Impact of COVID-19 Pandemic on Global Whole Exome Sequencing [WES] Market
3.2.1 Overview of Changing Landscape
3.2.2 Pre-covid & Post-Covid Market Analysis
3.3 Market Attractiveness Analysis
3.4 Regulatory Scenario
3.5 Industry Trend Analysis- Historic and Future Trend Assessment
3.6 Merger & Acquisition
3.7 New System Launch/Approvals
3.8 Market Analysis Tools
3.8.1 Porter’s Five Forces
3.8.2 PEST Analysis
3.8.3 Value Chain Analysis
3.9 Key Company Ranking Analysis, 2020
4 Global Whole Exome Sequencing [WES] Market Analysis and Forecast, By Type
4.1 Overview & Definition
4.2 Key Trends
4.3 Global Whole Exome Sequencing [WES] Market Value (US$ Mn) Forecast, by Type (2019 – 2028)
4.2.1 Agilent HaloPlex
4.2.2 Agilent SureSelect
4.2.3 Agilent SureSelect QXT
4.2.4 Illumina TruSeq Exome
4.2.5 Roche Nimblegen SeqCap
4.2.6 MYcroarray MYbaits
4.4 Type Comparison Matrix
4.5 Global Whole Exome Sequencing [WES] Market Attractiveness, By Type
5 Global Whole Exome Sequencing [WES] Market Analysis and Forecast, By Application
5.1 Overview & Definition
5.2 Key Trends
5.3 Global Whole Exome Sequencing [WES] Market Value (US$ Mn) Forecast, by Application (2019 – 2028)
5.3.1 Correlation Research of Normal Human
5.3.2 Mendelian Disease and Rare Syndrome Gene Discovery
5.3.3 The Research of Complex Diseases
5.3.4 Mouse Exome Sequencing
5.4 Application Comparison Matrix
5.5 Global Whole Exome Sequencing [WES] Market Attractiveness, by Application
6 Global Whole Exome Sequencing [WES] Market Analysis and Forecast, By Region
6.1 Overview & Definition
6.2 Key Trends
6.3 Global Whole Exome Sequencing [WES] Market Value (US$ Mn) Forecast, by Region (2019 – 2028)
6.4 North America
6.5 Europe
6.6 Asia Pacific
6.7 Latin America
6.8 Middle East & Africa
7 Global Whole Exome Sequencing [WES] Market Attractiveness, by Region
8 North America Whole Exome Sequencing [WES] Market Analysis and Forecast
8.1 Key Findings
8.2 North America Whole Exome Sequencing [WES] Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
8.2.1 Agilent HaloPlex
8.2.2 Agilent SureSelect
8.2.3 Agilent SureSelect QXT
8.2.4 Illumina TruSeq Exome
8.2.5 Roche Nimblegen SeqCap
8.2.6 MYcroarray MYbaits
8.3 North America Whole Exome Sequencing [WES] Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
8.3.1 Correlation Research of Normal Human
8.3.2 Mendelian Disease and Rare Syndrome Gene Discovery
8.3.3 The Research of Complex Diseases
8.3.4 Mouse Exome Sequencing
8.4 North America Whole Exome Sequencing [WES] Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
8.4.1 U.S.
8.4.2 Canada
8.4.3 Rest of North America
8.5 North America Whole Exome Sequencing [WES] Market Attractiveness Analysis
8.5.1 By Type
8.5.2 By Application
8.5.3 By Country
9 Europe Whole Exome Sequencing [WES] Market Analysis and Forecast
9.1 Key Findings
9.2 Europe Whole Exome Sequencing [WES] Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
9.2.1 Agilent HaloPlex
9.2.2 Agilent SureSelect
9.2.3 Agilent SureSelect QXT
9.2.4 Illumina TruSeq Exome
9.2.5 Roche Nimblegen SeqCap
9.2.6 MYcroarray MYbaits
9.3 Europe Whole Exome Sequencing [WES] Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
9.3.1 Correlation Research of Normal Human
9.3.2 Mendelian Disease and Rare Syndrome Gene Discovery
9.3.3 The Research of Complex Diseases
9.3.4 Mouse Exome Sequencing
9.4 Europe Whole Exome Sequencing [WES] Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
9.4.1 U.K.
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Rest of Europe
9.5 Europe Whole Exome Sequencing [WES] Market Attractiveness Analysis
9.5.1 By Type
9.5.2 By Application
9.5.3 By Country
10 Asia Pacific Whole Exome Sequencing [WES] Market Analysis and Forecast
10.1 Key Findings
10.2 Asia Pacific Whole Exome Sequencing [WES] Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
10.2.1 Agilent HaloPlex
10.2.2 Agilent SureSelect
10.2.3 Agilent SureSelect QXT
10.2.4 Illumina TruSeq Exome
10.2.5 Roche Nimblegen SeqCap
10.2.6 MYcroarray MYbaits
10.3 Asia Pacific Whole Exome Sequencing [WES] Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
10.3.1 Correlation Research of Normal Human
10.3.2 Mendelian Disease and Rare Syndrome Gene Discovery
10.3.3 The Research of Complex Diseases
10.3.4 Mouse Exome Sequencing
10.4 Asia Pacific Whole Exome Sequencing [WES] Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Asia Pacific Whole Exome Sequencing [WES] Market Attractiveness Analysis
10.5.1 By Type
10.5.2 By Application
10.5.3 By Country
11 Latin America Whole Exome Sequencing [WES] Market Analysis and Forecast
11.1 Key Findings
11.2 Latin America Whole Exome Sequencing [WES] Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
11.2.1 Agilent HaloPlex
11.2.2 Agilent SureSelect
11.2.3 Agilent SureSelect QXT
11.2.4 Illumina TruSeq Exome
11.2.5 Roche Nimblegen SeqCap
11.2.6 MYcroarray MYbaits
11.3 Latin America Whole Exome Sequencing [WES] Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
11.3.1 Correlation Research of Normal Human
11.3.2 Mendelian Disease and Rare Syndrome Gene Discovery
11.3.3 The Research of Complex Diseases
11.3.4 Mouse Exome Sequencing
11.4 Latin America Whole Exome Sequencing [WES] Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
11.4.1 Brazil
11.4.2 Rest of Latin America China
11.5 Latin America Whole Exome Sequencing [WES] Market Attractiveness Analysis
11.5.1 By Type
11.5.2 By Application
11.5.3 By Country
12 Middle East & Africa (MEA) Whole Exome Sequencing [WES] Market Analysis and Forecast
12.1 Key Findings
12.2 Middle East & Africa (MEA) Whole Exome Sequencing [WES] Market Analysis (US$ Mn) and Forecast, By Product Type (2019-2028)
12.2.1 Agilent HaloPlex
12.2.2 Agilent SureSelect
12.2.3 Agilent SureSelect QXT
12.2.4 Illumina TruSeq Exome
12.2.5 Roche Nimblegen SeqCap
12.2.6 MYcroarray MYbaits
12.3 Middle East & Africa (MEA) Whole Exome Sequencing [WES] Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
12.3.1 Correlation Research of Normal Human
12.3.2 Mendelian Disease and Rare Syndrome Gene Discovery
12.3.3 The Research of Complex Diseases
12.3.4 Mouse Exome Sequencing
12.4 Middle East & Africa (MEA) Whole Exome Sequencing [WES] Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
12.4.1 GCC Countries
12.4.2 South Africa
12.4.3 Rest of MEA
12.5 Middle East & Africa (MEA) Whole Exome Sequencing [WES] Market Attractiveness Analysis
12.5.1 By Type
12.5.2 By Application
12.5.3 By Country
13 Competitive Landscape
13.1 Market Players – Competition Matrix
13.2 Market Share Analysis by Key Players, 2020 (%)
13.3 Company Profiles
13.3.1 Illumina
13.3.1.1 Company Overview
13.3.1.2 Company Snapshot
13.3.1.3 Financial Overview
13.3.1.4 Product Portfolio
13.3.1.5 Key Developments/Strategies
13.3.2 Thermo Fisher
13.3.3 Roche
13.3.4 Angilent
13.3.5 Eurofins
13.3.6 Sengenics
13.3.7 Ambry
13.3.8 Macrogen
13.3.9 BGI
13.3.10 Novo Gene
14 Key Takeaways
Choose License Type